GB2052985A - Tryptophan for use in treating atherosclerosis - Google Patents

Tryptophan for use in treating atherosclerosis Download PDF

Info

Publication number
GB2052985A
GB2052985A GB8022202A GB8022202A GB2052985A GB 2052985 A GB2052985 A GB 2052985A GB 8022202 A GB8022202 A GB 8022202A GB 8022202 A GB8022202 A GB 8022202A GB 2052985 A GB2052985 A GB 2052985A
Authority
GB
United Kingdom
Prior art keywords
formula
compound
composition
residue
cis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB8022202A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of GB2052985A publication Critical patent/GB2052985A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB8022202A 1979-07-09 1980-07-07 Tryptophan for use in treating atherosclerosis Withdrawn GB2052985A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5580179A 1979-07-09 1979-07-09

Publications (1)

Publication Number Publication Date
GB2052985A true GB2052985A (en) 1981-02-04

Family

ID=22000247

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8022202A Withdrawn GB2052985A (en) 1979-07-09 1980-07-07 Tryptophan for use in treating atherosclerosis

Country Status (5)

Country Link
JP (1) JPS5632457A (enExample)
DE (1) DE3024739A1 (enExample)
FR (1) FR2460931A1 (enExample)
GB (1) GB2052985A (enExample)
IT (1) IT8049188A0 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0106281A3 (en) * 1982-10-07 1985-01-09 Yeda Research And Development Company, Ltd. Analgesia-effecting 5-hydroxytryptophan derivatives
US12370161B2 (en) 2017-11-24 2025-07-29 Stemdr Inc. Composition for treating atopy or pruritus comprising N-acetyl or N-acyl amino acid

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0106281A3 (en) * 1982-10-07 1985-01-09 Yeda Research And Development Company, Ltd. Analgesia-effecting 5-hydroxytryptophan derivatives
US12370161B2 (en) 2017-11-24 2025-07-29 Stemdr Inc. Composition for treating atopy or pruritus comprising N-acetyl or N-acyl amino acid

Also Published As

Publication number Publication date
IT8049188A0 (it) 1980-07-08
FR2460931B1 (enExample) 1983-06-24
DE3024739A1 (de) 1981-01-29
FR2460931A1 (fr) 1981-01-30
JPS5632457A (en) 1981-04-01

Similar Documents

Publication Publication Date Title
US4078084A (en) Novel hypolipidemic 2-(3,5-di-tert-butyl-4-hydroxyphenyl)thio carboxamides
US4448785A (en) N-Unsaturated fatty acid amides of tryptophan ester homologues and anti-cholesteric use thereof
JPH0597765A (ja) ナフトキノン化合物
KR900001287B1 (ko) 나프토퀴논류의 제조방법
US4582857A (en) Novel p-oxybenzoic acid derivatives, processes for their production and their use as drugs
US4594443A (en) Derivatives of 4-phenyl-4-oxo-buten-2-oic acid and therapeutic use thereof
US4461775A (en) Hydroxythioether fatty acid derivatives
US4012523A (en) Hypolipidemic 2-(3,5-di-tert-butyl-4-hydroxyphenyl)-(thio or sulfonyl) alkanoic acids and derivatives
US4067998A (en) 2-((3,5-Di-tert-butylphenyl)thio) alkanoic acids and derivatives
US4806568A (en) Gossypol derivatives
US3812109A (en) Substituted indenyl glucoronide esters
US4469705A (en) Saturated leukotriene derivatives as antiallergens
GB2052985A (en) Tryptophan for use in treating atherosclerosis
FR2515175A1 (fr) Nouveaux derives de l'acide 4-phenyl 4-oxo 2-butenoique, leurs sels, leur preparation, leur application comme medicaments et les compositions les renfermant
US5523310A (en) 1,2,3-triazole derivatives
BE897068A (fr) Nouveau derive de la pyrazolo [1,5-a] pyridine sa preparation et les compositions pharmaceutiques qui les contiennent
US4407825A (en) Novel bis- and poly-disulfides having immunostimulant activity
DE69515498T2 (de) Naphthyridinderivate
US4062975A (en) Amino substituted arylthio-alkanoic acids having hypolipidemic activity
CA1037964A (en) 2-((3,5-di-tert-buryl-4-hydroxyphenyl)thio)alkanoic acids and derivatives and esters
EP0041826B1 (en) 4-(n-(substituted-benzylidene)aminomethyl)cyclohexane-1-carboxylic acids
US4133890A (en) Hypolipidemic compositions and method employing derivatives of 4-(((1,3-benzodioxol-5-yl)methyl)amino)benzoic acid
EP0047358B1 (en) Indol acetic derivatives, process for producing the same and pharmaceutical compositions comprising the same
US3558626A (en) 2-(4 - (diphenyl-2-pyrimidinyl)phenoxy) lower aliphatic monocarbocyclic acids and esters
PL70292B1 (enExample)

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)